Imexpharm Corporation (HOSE: IMP)
Health Care · Pharmaceuticals · VN
₫37,000.00
+1.09% today · -27.5% 1Y
Imexpharm Corporation (HOSE: IMP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $220.14M.
Over the last twelve months the share price has lost 27.5%, trading between 32.65K and 57.00K.
Tweenvest scores Imexpharm Corporation across four factors: quality 83/100, value 67/100, growth 54/100, dividend 31/100. Its strongest factor is quality.
IMP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $220.14M
- Revenue (TTM)
- $88.25M
- P/E
- 18.13
- EPS
- 2,041.17
- Dividend yield
- 1.35%
- Beta (5Y)
- 0.43
- 52-week high
- ₫57,000.00
- 52-week low
- ₫32,650.00
- Avg volume (3M)
- —
- Shares outstanding
- 154.01M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Savior Lifetec CorporationTPEX: 4167 | $228.12M | NT$22.00 | +12.53% |
| Syncom Formulations (India) LimitedBSE: 524470 | $225.92M | Rs23.26 | -2.96% |
| Sai Parenteral's LimitedNSEI: SAIPARENT | $225.46M | Rs493.90 | -5.68% |
| Venus Remedies LimitedBSE: 526953 | $225.23M | Rs1,630.75 | -8.61% |
| Indoco Remedies LimitedNSEI: INDOCO | $220.03M | Rs230.70 | -8.36% |
| JW Holdings CorporationKOSE: A096760 | $211.27M | ₩4,105.00 | -4.20% |
| Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)CASE: RMDA | $210.00M | EGP5.41 | -0.73% |
| Huons Global Co., Ltd.KOSDAQ: A084110 | $209.76M | ₩23,100.00 | +2.44% |
Figures last refreshed Oct 11, 2026.